Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Multiparameter Tests for Identifying Women with Early Breast Cancer Who Do Not Need Adjuvant Chemotherapy

Published:2017-04-01 Issue:4 Volume:63 Page:804-806
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Duffy Michael J¹²,McDermott Enda W²,Crown John³

Affiliation:

1. Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland

2. UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

3. Medical Oncology Department, St. Vincent's University Hospital, Dublin, Ireland

Funder

Cancer Clinical Research Trust

Science Foundation Ireland

Strategic Research Cluster Award

Molecular Therapeutics for Cancer Ireland

BREAST-PREDICT

Irish Cancer Society

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/63/4/804/32646036/clinchem0804.pdf

Reference5 articles.

1. Clinical use of biomarkers in breast cancer: updated guidelines from the European Group on Tumor Markers (EGTM);Duffy;Eur J Cancer,2017

2. on behalf of the European Commission supported TRANSBIG consortium and MINDACT investigators. The 70-gene signature as an aid to treatment decisions in early breast cancer;Cardoso;N Engl J Med,2016

3. Gene expression profiling predicts clinical outcome of breast cancer;van't Veer;Nature,2002

4. Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis;Augustovski;Breast Cancer Res Treat,2015

5. Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no test is more equal than the others;Bartlett;J Natl Cancer Inst,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introducing effective genes in lymph node metastasis of breast cancer patients using SHAP values based on the mRNA expression data;PLOS ONE;2024-08-16

2. Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA);Breast Cancer Research and Treatment;2024-02-15

3. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis;International Journal of Molecular Sciences;2023-11-06

4. SIK2‐positive tumor epithelial cells in breast cancer maybe potential anti‐cancer messengers: A systematic analysis from a single‐cell perspective;Environmental Toxicology;2023-09-29

5. Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach;The International Journal of Biological Markers;2022-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3